The SMART4MD tool, developed in this project, will help patients to adhere to their treatment, reduce the progression of their illness and share data with their carers and doctors. This will slow the patients’ cognitive and functional decline, avoid carers getting exhausted and reduce costs of emergency care.
Design a new version of the Pow Health platform (called SMART4MD platform) that can be comfortably and reliably used by patients with MD, validated by at least 80% approval rate in focus groups and small scale patient trials.
Show the medical benefits of using the new SMART4MD platform:
Increase treatment compliance by MD patients from 50% to 60%.
Reduce functional decline of patients during the first 24 months from diagnosis by 10%.
Monitor and improve the quality of life for MD patients
Monitor the mental well-being of carers
Show the economic and financial benefits of using the SMART4MD platform:
Reduce costs wasted on unused medicine by 50%.
Reduce costs associated with patients failing to attend appointments by 75%.
Reduce costs associated with readmission of patients to hospital (for resurgent conditions due to lack of treatment adherence) by 30%.
Provide overall efficiency savings to the healthcare system of 10% of dementia budget.
Develop sustainable business models for large-scale commercial roll-out of the SMART4MD platform in different scenarios and regions. Include financial models for investment, based on risk-sharing between relevant stakeholders and provide projections for each stakeholder’s return on investment to complete the economic argument.
SMART4MD is co-financed by the European Union under an EU Framework Programme for Research and Innovation - Horizon 2020, with grant agreement number 643399.